Concepedia

Masahiko Sato

MS

Statistics

Publications

83

Citations

7K

H-Index

38

Active since

1979

Affiliations

Eli Lilly (United States)(Current)

Indiana University – Purdue University Indianapolis

The University of Tokyo

Indiana University School of Medicine

United States Military Academy

Masahiko Sato is an author at Eli Lilly (United States) specializing in medicine, bone metabolism, and endocrinology.

ORCID

Publications per year

1979–2024

83

Publications

83

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

, , +14

Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety

John L. Vahle, Masahiko Sato, Gerald G. Long et al. · Toxicologic Pathology · 2002 · 696 citations · Full text

, , +16

Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose

John L. Vahle, Gerald G. Long, George E. Sandusky et al. · Toxicologic Pathology · 2004 · 371 citations

, , +13

Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)

Yaser M. Alkhiary, Louis C. Gerstenfeld, Elizabeth A. Krall et al. · Journal of Bone and Joint Surgery · 2005 · 302 citations

, , +17

Effects of bisphosphonates on isolated Rat osteoclasts as examined by reflected light microscopy

Masahiko Sato, W A Grasser · Journal of Bone and Mineral Research · 1990 · 268 citations

, , +13

1–5 of 83